PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.3523
-0.0239 (-6.35%)
At close: Nov 5, 2025, 4:00 PM EST
0.3525
+0.0002 (0.06%)
Pre-market: Nov 6, 2025, 6:43 AM EST
PAVmed Market Cap
PAVmed has a market cap or net worth of $9.16 million as of November 6, 2025. Its market cap has decreased by -15.21% in one year.
Market Cap
9.16M
Enterprise Value
14.09M
1-Year Change
-15.21%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since July 28, 2016, PAVmed's market cap has decreased from $173.00M to $9.16M, a decrease of -94.71%. That is a compound annual growth rate of -27.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 8.20M | 18.84% |
| Dec 31, 2024 | 6.90M | -79.22% |
| Dec 29, 2023 | 33.20M | -26.22% |
| Dec 30, 2022 | 45.00M | -79.20% |
| Dec 31, 2021 | 216.30M | 95.22% |
| Dec 31, 2020 | 110.80M | 151.25% |
| Dec 31, 2019 | 44.10M | 72.94% |
| Dec 31, 2018 | 25.50M | -19.56% |
| Dec 29, 2017 | 31.70M | -65.47% |
| Dec 30, 2016 | 91.80M | -46.94% |
| Jul 28, 2016 | 173.00M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 847.24B |
| Johnson & Johnson | 449.84B |
| AbbVie | 377.42B |
| UnitedHealth Group | 294.61B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 217.27B |
| Novo Nordisk | 215.64B |